Biden Advances Schedule For COVID Vaccine Eligibility As Experts Warn Americans, ‘The War Is Not Yet Won’

The US COVID-19 vaccine push received another push Tuesday, with President Joe Biden expected to announce that all Americans will be eligible for a jab by April 19, pushing forward an earlier deadline of April 1. of May.

The Centers for Disease Control and Prevention’s vaccine tracker shows that as of 6:00 a.m. ET Monday, 207.9 million doses had been delivered to states, 167.2 million doses had been administered, and 107.5 million people had received at least one of a two-dose regimen. equal to 32.4% of the population. In total, 62.4 million people are fully vaccinated, meaning they have received two injections of the two-dose vaccines developed by Pfizer Inc. PFE, + 0.21% and German partner BioNTech SE BNTX, + 1, 52% and Moderna Inc. MRNA, + 2.66% or one of Johnson & Johnson’s JNJ, + 0.54% single injection vaccine. That equates to 18.8% of the population. In the age group 65 and over, 30 million people are fully vaccinated, more than half (54.9%) of that population. In some states, that number is even higher.

media-object type-InsetMediaIllustration inline article__inset article__inset–type-InsetMediaIllustration article__inset–inline “>

media article__inset__image__image”>

CDC Vaccine Tracker

Still, the cases continue to rise and experts are concerned. The United States added at least 76,594 new cases Monday, according to a New York Times tracker, and at least 530 people died. The United States has averaged 64,581 cases a day over the past week, 20% more than the average two weeks ago. Experts worry that the seven-day average remains higher than the 14-day average, blaming pandemic fatigue after a year of movement restrictions, and while some states abandon face mask mandates. The White House COVID Task Force and other health experts have repeatedly asked Americans to adhere to public safety measures, namely frequent hand washing, social distancing and wearing a mask in public, even after to be fully vaccinated. A Gallup poll released Tuesday found that Americans’ concerns about contracting the virus have fallen to an all-time low. Only 35% of adults say they are very or somewhat concerned about contracting COVID, the lowest level since April 2020, and down from 49% in the latest survey.

Source: Gallup poll

Andy Slavitt, the White House‘s senior adviser for the national response to COVID-19, told reporters at a press conference Monday at the White House that the United States is heading in the right direction. “But as you heard the president say: we haven’t arrived yet. The war on COVID-19 is far from over, far from being won. The worst thing we could do right now would be to mistake progress for victory. If we let our guard down now, we will see more of our countrymen get sick and die unnecessarily. “CDC Director Dr. Rochelle Walensky agreed, noting that most of the increasing cases nationwide involve younger adults, who are being infected with new, more communicable variants, as they begin to playing sports and other extracurricular activities again. “I understand that people are tired and ready for this pandemic to end, like me,” he said. “Please continue to hold out and do the things we know how to prevent the spread of the virus.” In other news: • Catalent Inc. CTLT, + 1.13%, a contract drug manufacturer, is expanding US production of the COVID-19 vaccine developed by Moderna Inc. and will nearly double production at its Bloomington, Indiana plant to about 400 vials per minute in April, the companies said, confirming a Wall Street Journal report. The plant will be able to produce an additional 80 million vials a year and will begin shipping new doses in May, the people said. The move will help Moderna reach its goal of delivering an additional 100 million doses to the US government by the end of May and another 100 million by the end of July. Don’t Miss: How 6 Feet Became 3: Meet An ER Physician Behind Research Showing Kids Are Still Safe At School With A New Standard Of Social Distancing • Dynavax Technologies Corp. DVAX, + 2.90% said Tuesday that French vaccine manufacturer Valneva plans to begin a Phase 3 trial of its inactivated COVID-19 vaccine candidate, VLA2001, with Dynavax’s CpG 1018 (TM) adjuvant in late April after achieving positive results in a trial. Phase 1/2. The trial involved 153 healthy adults ages 18 to 55 and found the combination to be safe and highly immunogenic. The group that administered the highest dose produced antibodies and T cells and showed only mild to moderate adverse effects. “We believe that the effect delivered by our adjuvant CpG 1018 combined with Valneva’s existing manufacturing process for whole virus inactivated vaccines will result in an important option in the global fight against COVID-19,” said Dynavax CEO Ryan Spencer, in a statement. • Residents of Australia and New Zealand will be able to travel between the two nations without having to self-quarantine from April 19, the BBC reported. Since October, New Zealand travelers have been allowed to enter most Australian states without quarantine, although this had not been reciprocated. Since then, both nations have contained COVID outbreaks and kept infection rates close to zero. The countries closed their borders in March last year and introduced a mandatory quarantine for returning nationals.

Images of crowded nightclubs in Tel Aviv contrast with scenes of locked-in Paris over Easter weekend, highlighting how staggered vaccine launches are affecting the speed at which countries reopen amid the pandemic. Photo: Helem Tarbut / AP, Ian Langsdon / Shutterstock

See also: Vaccines are here. That is no reason to suspend the search for effective COVID-19 treatments. • North Korea will not attend the upcoming Tokyo Olympics for fear that its athletes may contract COVID, CNN reported. North Korea decided to cut almost all of its ties to the outside world in 2020 to prevent an influx of coronavirus cases. The country has not reported a major outbreak of the deadly disease and there has been no indication that it has occurred, although experts doubt Pyongyang’s claim that the country has not seen a single case of the virus. Foreign diplomats and aid workers have also fled the country en masse in recent months, citing shortages of goods and extreme restrictions on daily life, according to the Russian Embassy in Pyongyang. • The European drug regulator, the European Medicines Agency, denied on Tuesday that it found a clear link between the AstraZeneca PLC AZN vaccine, + 0.11% AZN, -0.06% developed with the University of Oxford and a blood clotting syndrome, after a senior official said there was a link, The Guardian reported. The EMA said the review is ongoing and that it expected to announce the findings later this week. Several countries stopped the use of the AstraZeneca vaccine in recent weeks due to blood clotting events in a small number of patients. France, Germany, Italy, France, Spain, the Netherlands and Canada have suspended its administration in people under 55, 60 or 65 years old. Watch now: CDC offers travel advice for vaccinated Americans, but falls short of saying it’s okay to get on a planeLatest finds that the global count of coronavirus-borne diseases rose above 131.8 million on Tuesday, according to aggregate data by Johns Hopkins University, while the death toll exceeded 2.86 million. Almost 75 million people have recovered from COVID, the data shows. The United States continues to lead the world for cases, with 30.8 million, or about a quarter of the global count, and deaths, with 555,619. Brazil ranks second worldwide in cases with 13 million and also second with a death toll of 332,752. India ranks third in the world in cases with 12.7 million and fourth in deaths with 165,547. Mexico ranks third for deaths with 204,399 and 14th highest for cases with 2.3 million. The UK has 4.4 million cases and 127,106 deaths, the highest in Europe and the fifth highest in the world. China, where the virus was first discovered late last year, has had 101,908 confirmed cases and 4,841 deaths, according to its official figures. What does the economy say? Job openings in the U.S. spiked in February to the highest level in more than two years as the economy emerged from a winter slumber linked to a record spike in coronavirus cases, MarketWatch’s Jeffry Bartash reported. The number of job openings rose to 7.37 million from 7.1 million in January, the Labor Department said Tuesday. The economy began to accelerate early in the new year after a sharp decline in coronavirus cases. Rising vaccines, relaxed government trade restrictions, and another massive dose of federal stimulus have all contributed to the economy roiling, with faster growth expected in the coming months. Last Friday, the government said the United States gained 916,000 new jobs in March in another clear sign that the economy is strengthening. The International Monetary Fund on Tuesday raised its global economic outlook, citing a much brighter outlook for the US economy, MarketWatch’s Greg Robb reported. The IMF dramatically raised its outlook for the US in 2021 to 6.4% this year from 5.1%. The US should see a solid growth of 4.4% in 2022. The Fed forecasts that the US economy will grow at a rate of 6.5% this year, but with a more pronounced slowdown at a rate of growth from 3.3% in 2022. The IMF raised its estimate of world growth to 6%. this year and 4.4% next. This represents an improvement of 0.5% for 2021 and 0.2% for 2022 over what it forecast in January. Gita Gopinath, IMF economic adviser, said that “a way out of this economic and health crisis is increasingly visible.” Medium-term losses from the pandemic are likely to be lower than those after the financial crisis. But this time around, low-income countries and emerging markets will suffer the most compared to the consequences of the Great Recession. The Dow Jones Industrial Average DJIA, -0.09% and the S&P 500 SPX, + 0.06% were unchanged on Tuesday. Also read: The dangers of uneven global growth and how to avoid that trap